TY - JOUR
T1 - The mTOR regulated RNA-binding protein LARP1 requires PABPC1 for guided mRNA interaction
AU - Smith, Ewan M.
AU - Benbahouche, Nour El Houda
AU - Morris, Katherine
AU - Wilczynska, Ania
AU - Gillen, Sarah
AU - Schmidt, Tobias
AU - Meijer, Hedda A.
AU - Jukes-Jones, Rebekah
AU - Cain, Kelvin
AU - Jones, Carolyn
AU - Stoneley, Mark
AU - Waldron, Joseph A.
AU - Bell, Cameron
AU - Fonseca, Bruno D.
AU - Blagden, Sarah
AU - Willis, Anne E.
AU - Bushell, Martin
N1 - Funding Information:
Biotechnology and Biological Sciences Research Council [BB/H024980/1 to A.E.W.]; Medical Research Council [MC UP A600 1024 to M.B.]; Cancer Research UK [A29252, A31287]; Cancer Research UK SMERP award [A22598 to S.B., N.B.]; K.M. was funded through the Medical Research Council [1243972]. Funding for open access charge: Cancer Research UK [A31287].
Publisher Copyright:
© 2021 The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/1/11
Y1 - 2021/1/11
N2 - The mammalian target of rapamycin (mTOR) is a critical regulator of cell growth, integrating multiple signalling cues and pathways. Key among the downstream activities of mTOR is the control of the protein synthesis machinery. This is achieved, in part, via the co-ordinated regulation of mRNAs that contain a terminal oligopyrimidine tract (TOP) at their 5'ends, although the mechanisms by which this occurs downstream of mTOR signalling are still unclear. We used RNA-binding protein (RBP) capture to identify changes in the protein-RNA interaction landscape following mTOR inhibition. Upon mTOR inhibition, the binding of LARP1 to a number of mRNAs, including TOP-containing mRNAs, increased. Importantly, non-TOP-containing mRNAs bound by LARP1 are in a translationally-repressed state, even under control conditions. The mRNA interactome of the LARP1-associated protein PABPC1 was found to have a high degree of overlap with that of LARP1 and our data show that PABPC1 is required for the association of LARP1 with its specific mRNA targets. Finally, we demonstrate that mRNAs, including those encoding proteins critical for cell growth and survival, are translationally repressed when bound by both LARP1 and PABPC1.
AB - The mammalian target of rapamycin (mTOR) is a critical regulator of cell growth, integrating multiple signalling cues and pathways. Key among the downstream activities of mTOR is the control of the protein synthesis machinery. This is achieved, in part, via the co-ordinated regulation of mRNAs that contain a terminal oligopyrimidine tract (TOP) at their 5'ends, although the mechanisms by which this occurs downstream of mTOR signalling are still unclear. We used RNA-binding protein (RBP) capture to identify changes in the protein-RNA interaction landscape following mTOR inhibition. Upon mTOR inhibition, the binding of LARP1 to a number of mRNAs, including TOP-containing mRNAs, increased. Importantly, non-TOP-containing mRNAs bound by LARP1 are in a translationally-repressed state, even under control conditions. The mRNA interactome of the LARP1-associated protein PABPC1 was found to have a high degree of overlap with that of LARP1 and our data show that PABPC1 is required for the association of LARP1 with its specific mRNA targets. Finally, we demonstrate that mRNAs, including those encoding proteins critical for cell growth and survival, are translationally repressed when bound by both LARP1 and PABPC1.
UR - http://www.scopus.com/inward/record.url?scp=85099721690&partnerID=8YFLogxK
U2 - 10.1093/nar/gkaa1189
DO - 10.1093/nar/gkaa1189
M3 - Article
C2 - 33332560
SN - 0305-1048
VL - 49
SP - 458
EP - 478
JO - Nucleic Acids Research
JF - Nucleic Acids Research
IS - 1
ER -